Wet AMD 3 Symposium

Related

• 

  Differences in Intravitreal Silicone Oil Following Multiple Bevacizumab, Ranibizumab, and Aflibercept Injections

  John T. Thompson, MD

  Annual Meeting Talks

  2019

• 

  Long-term Anti-VEGF Treatment Following Vitrectomy for Endophthalmitis in Patients With Neovascular AMD

  Zofia Anna Nawrocka (vel Michalewska), MD, PhD

  Annual Meeting Talks

  2018

• 

  Are There Safety Concerns With Bevacizumab for ROP

  Robert L. Avery, MD

  Updates from the Field

  2017